| P2093 | author name string | M Zarrindast | |
| | S Valizadeh | |
| | M Sahebgharani | |
| P2860 | cites work | Psychogenic facial pain: presentation and treatment | Q24543998 |
| | The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy | Q28317172 |
| | A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. | Q33510083 |
| | (-)Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor. | Q34251383 |
| | The use of antidepressants in the treatment of chronic pain. A review of the current evidence | Q36711535 |
| | Spinal cord stimulation attenuates augmented dorsal horn release of excitatory amino acids in mononeuropathy via a GABAergic mechanism | Q39451835 |
| | Role of glutamate receptors and nitric oxide in the rostral ventromedial medulla in visceral hyperalgesia | Q39480227 |
| | Morphine responsiveness of chronic pain: double-blind randomised crossover study with patient-controlled analgesia | Q39501373 |
| | Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy | Q39501933 |
| | Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia | Q39508711 |
| | GABAergic mechanisms of analgesia: an update | Q39508829 |
| | Association of pain relief with drug side effects in postherpetic neuralgia: a single-dose study of clonidine, codeine, ibuprofen, and placebo | Q39532706 |
| | Pain relief by antidepressants: possible modes of action | Q39547686 |
| | Drug therapy: spasticity (second of two parts). | Q40295363 |
| | The pathophysiology of chronic pain--increased sensitivity to low threshold A beta-fibre inputs. | Q40563563 |
| | GABAB receptor pharmacology | Q40854043 |
| | Benzodiazepines as antidepressants: does GABA play a role in depression? | Q40952779 |
| | Modulation of neuropathic pain behavior in rats by spinal disinhibition and NMDA receptor blockade of injury discharge | Q41134718 |
| | Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain. | Q41652154 |
| | Selective modulation of morphine antinociception, but not development of tolerance, by delta receptor agonists | Q41790440 |
| | Gamma-aminobutyric acid can both inhibit and facilitate dopamine release in the caudate nucleus of the rabbit | Q42468938 |
| | Characteristics of GABAB receptor binding sites on rat whole brain synaptic membranes | Q42635308 |
| | GABAB-receptor mediated inhibition of potassium-evoked release of endogenous 5-hydroxytryptamine from mouse frontal cortex | Q42849913 |
| | Potentiation of opioid analgesia by the antidepressant nefazodone | Q44331196 |
| | CGP 35348: a centrally active blocker of GABAB receptors | Q44810216 |
| | Neuropathic pain can be relieved by drugs that are use-dependent sodium channel blockers: lidocaine, carbamazepine, and mexiletine | Q44918521 |
| | Spinal 5-HT3 receptor-mediated antinociception: possible release of GABA. | Q45282606 |
| | Baclofen: effects on amino acid release and metabolism in slices of guinea pig cerebral cortex | Q46487639 |
| | Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain | Q48097606 |
| | Morphine differentially affects the sensory and affective pain ratings in neurogenic and idiopathic forms of pain. | Q51157064 |
| | The effectiveness of spinal and systemic morphine on rat dorsal horn neuronal responses in the spinal nerve ligation model of neuropathic pain | Q60679672 |
| | Stability of plasma GABA at four-year follow-up in patients with primary unipolar depression | Q61480115 |
| | GABAA-antagonists and baclofen analgesia | Q68013129 |
| | Can opiates relieve neuropathic pain? | Q68032994 |
| | Antinociceptive effects of acute and ‘chronic’ injections of tricyclic antidepressant drugs in a new model of mononeuropathy in rats | Q68161374 |
| | Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up | Q70351578 |
| | CSF GABA in normal subjects and patients with depression, schizophrenia, mania, and anorexia nervosa | Q70858241 |
| | The pharmacology of adenylyl cyclase modulation by GABAB receptors in rat brain slices | Q71719221 |
| | Time-course of nociceptive disorders induced by chronic loose ligatures of the rat sciatic nerve and changes of the acetylcholinesterase transport along the ligated nerve | Q72137035 |
| | Baclofen and antidepressant--induced antinociception in formalin test: possible GABA(B) mechanism involvement | Q77402428 |
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 65-72 | |
| P577 | publication date | 2000-10-01 | |
| P1433 | published in | European Journal of Pharmacology | Q1376712 |
| P1476 | title | GABA(B) receptor mechanism and imipramine-induced antinociception in ligated and non-ligated mice | |
| P478 | volume | 407 | |